Curry’s ability to fight cancer put to the test
A chemical found in curry is to be tested for its ability to kill bowel cancer tumours in patients. Curcumin, which is found in the spice turmeric, has been linked to a range of health benefits. Studies have already shown that it can beat cancer cells grown in a laboratory and benefits have been suggested in stroke and dementia patients as well. Now a trial at hospitals in Leicester will be investigating giving curcumin alongside chemotherapy drugs. About 40,000 people are diagnosed with bowel cancer in the UK each year.
If the disease spreads around the body, patients are normally given a combination of three chemotherapy drugs, but about half will not respond. Forty patients at Leicester Royal Infirmary and Leicester General Hospital will take part in the trial, which will compare the effects of giving curcumin pills seven days before starting standard chemotherapy treatment. Prof William Steward, from Leicester University, who is leading the study, said animal tests combining the two were "100 times better" than either on their own and that had been the "major justification for cracking on" with the trial. He said: "Once bowel cancer has spread it is very difficult to treat, partly because the side effects of chemotherapy can limit how long patients can have treatment.
"The prospect that curcumin might increase the sensitivity of cancer cells to chemotherapy is exciting because it could mean giving lower doses, so patients have fewer side effects and can keep having treatment for longer. "This research is at a very early stage, but investigating the potential of plant chemicals to treat cancer is an intriguing area that we hope could provide clues to developing new drugs in the future." Joanna Reynolds, from Cancer Research UK, said: "By doing a clinical trial like this, we will find out more about the potential benefits of taking large amounts of curcumin, as well as any possible side effects this could have for cancer patients."
--
Advertise with us! Call (Trinidad) (868) 297-2500 (Guyana) (592) 609-3084 - or email pellaumagazine@gmail.com for more info! Also visit http://pellau.tk
Dexter Tittil
General Manager
Pellau Group
http://www.pellau.tk
On Wed, 9 May 2012 21:28:06 -0400, Dexter Tittil wrote:
>
>
> Thursday, May 10, 2012
>
>
>
> from The Trinidad Guardian Newspaper http://www.guardian.co.tt/lifestyle/2012-05-09/curry%E2%80%99s-ability-fight-cancer-put-test
>
Business owners Sign up here for Free
Can You Have More Sales, Too?
Helping over 120,000+ businesses like yours raise profits and build customer relationships using AWeber's opt-in email marketing software for over 10 years.
Trending Articles This Week
-
News 4 new results for hollywood The 'ultimate pay-per-view': How Hollywood's mega rich are spending vast sums ... Daily Mai...
-
Click here to share us on facebook! Congratulations to Soca star Kees Dieffenthaller, who wed his longtime girlfriend Teri Leigh Bove...
-
News 4 new results for pop music Today's Playlist: Is the Sax Dead in Pop Music ? The Takeaway (blog) Clemons was a saxophonist in Br...
-
Known for her trademark dances and waist defying movements, Belfon plans to mark the occasion with the launch of her alter ego Lady Boldfa...
-
News 2 new results for hollywood ISPs to Disrupt Internet Access of Copyright Scofflaws Wired News (blog) By David Kravets The nation...
-
Minister of Works and Infrastructure and Member of Parliament for Chaguanas West, Jack Warner, says the East Indians who migrated from India...
-
Video 4 new results for Fashion 3D Dsquared2 Show @ Milan Fashion Week Spring ... 5 min youtube.com MILAN - It's FashionTV in 3D! Fa...
-
News 5 new results for fashion Your Morning Fashion and Beauty Report: Elle Fanning meets Paris Haute Couture ... Los Angeles Times (blo...
-
Click here to share us on facebook! Reigning International Power Soca Monarch and Groovy Soca Monarch, Machel Montano on March 24 hel...
-
This is the video everyone is talking about. What do you think about it? Is it as horrible as everyone describes? Click ...
0 comments:
Post a Comment